Lambert Potin
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lymphatic System and Diseases
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 5
- Lymphatic System and Diseases 4
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 2
- Co-authors
- Melody A. Swartz (11 shared papers)Peyman Hosseinchi (5 shared papers)Ako Ishihara (5 shared papers)Jeffrey A Hubbell (5 shared papers)Jun Ishihara (5 shared papers)Aslan Mansurov (3 shared papers)John‐Michael Williford (3 shared papers)Kazuto Fukunaga (3 shared papers)
- Journals
- Science Translational Medicine (3 papers)The Journal of Experimental Medicine (2 papers)Advanced Drug Delivery Reviews (1 paper)Mucosal Immunology (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Lambert Potin
12 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 78
- Immunology 651
- Oncology 720
- Immunology and Allergy 60
- Biotechnology 53
- Molecular Biology 389
Countries citing papers authored by Lambert Potin
This map shows the geographic impact of Lambert Potin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lambert Potin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lambert Potin more than expected).
Fields of papers citing papers by Lambert Potin
This network shows the impact of papers produced by Lambert Potin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lambert Potin. The network helps show where Lambert Potin may publish in the future.
Co-authors
The 25 scholars most cited alongside Lambert Potin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 213 | |
| 2 | 2014 | 199 | |
| 3 | 2020 | 197 | |
| 4 | 2019 | 160 | |
| 5 | 2017 | 144 | |
| 6 | 2019 | 111 | |
| 7 | 2019 | 107 | |
| 8 | 2017 | 96 | |
| 9 | 2018 | 36 | |
| 10 | 2012 | 25 | |
| 11 | 2020 | 13 | |
| 12 | 2023 | 3 |
About Lambert Potin
Lambert Potin is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Surgery and Pathology and Forensic Medicine, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lymphatic System and Diseases (4 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Lymphatic Disorders and Treatments (2 papers) and Vascular Malformations and Hemangiomas (2 papers). The work is most often cited by research in Immunology (651 citations), Oncology (720 citations), Immunology and Allergy (60 citations), Biotechnology (53 citations) and Molecular Biology (389 citations). Lambert Potin has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Melody A. Swartz, Peyman Hosseinchi, Ako Ishihara, Jeffrey A Hubbell, Jun Ishihara, Aslan Mansurov, John‐Michael Williford, Kazuto Fukunaga, Tiffany M. Marchell and Laura T. Gray. Their work appears in journals such as Science Translational Medicine, The Journal of Experimental Medicine, Advanced Drug Delivery Reviews, Mucosal Immunology and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.